Literature DB >> 23433738

First-line treatment of indolent lymphoma: axing CHOP?

Caron A Jacobson1, Arnold S Freedman.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23433738     DOI： 10.1016/S0140-6736(12)61965-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström's Macroglobulinemia.

Authors:  Abdullah Mohammad Khan
Journal:  J Pers Med       Date:  2022-04-22

2.  Management of mantle cell leukemia with cardiac involvement leading to cardiogenic shock.

Authors:  Muhammad Furqan; Yamei Chen; Akintunde Akinleye; Judy Sarungbam; Alan Gass; Karen Seiter; Delong Liu
Journal:  Front Med       Date:  2014-03-14       Impact factor: 4.592
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.